It can be used as an alternative material for human corneal epithelial tissue.
The "LabCyte CORNEA-MODEL" is a three-dimensional human cultured corneal epithelium that is cultured using human normal corneal epithelial cells and has been stratified. It has a structure that is morphologically similar to human corneal epithelial tissue. Additionally, because it is manufactured using the medical corneal culture technology developed by our company, it has excellent quality stability and yields highly reproducible evaluation test results. 【Features】 ■ Reproduces human corneal epithelial structure - Usable for ocular irritation testing - Analysis possible using corneal epithelial expressed proteins as indicators - Achieves low inter-batch and inter-lot variability *For more details, please download the PDF or contact us.
Inquire About This Product
basic information
【Test Example】 ■Irritation Test Using Corneal Model ・You can examine the eye irritation of various compounds using a corneal model. *For more details, please download the PDF or contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（2）
Download All Catalogs
![[Research Reagent] Human 3D Cultured Corneal Epithelium 'LabSite Corneal Model'](https://image.mono.ipros.com/public/catalog/image/01/857/496842/IPROS18405276372025169627.jpeg?w=120&h=170)
Company information
Our company is a biotechnology firm with the purpose of "developing a business that aims to fundamentally change healthcare in the 21st century, based on tissue engineering that brings about qualitative changes in medical care and aims for regenerative treatment." Our main business objectives include research and development, manufacturing, and sales of regenerative medicine products and related products. We operate a "Regenerative Medicine Products Business" that is subject to the Pharmaceuticals and Medical Devices Act, and a "Research and Development Support Business" that is not subject to this act. Additionally, we provide contract development and manufacturing (CDMO) and contract research organization (CRO) services related to regenerative medicine products, as well as support for compliance with the Act on Ensuring Safety in Regenerative Medicine through our "Regenerative Medicine Contract Business."